Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zile

Showing results (831-840 of 1,060) with videos related to

Pageof 106
Sort By:
Journal of the American College of Cardiology|November 5, 2013
Impaired systolic function by strain imaging in heart failure with preserved ejection fractionElisabeth Kraigher-Krainer, Amil M Shah, Deepak K Gupta, et al.
American Heart Journal|February 23, 2021
Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trialsMuhammad Shahzeb Khan, Soren Lund Kristensen, Muthiah Vaduganathan, et al.
JACC. Heart Failure|May 13, 2019
Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HFCraig Balmforth, Joanne Simpson, Li Shen, et al.
Journal of the American College of Cardiology|November 18, 2017
Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection FractionUlrik M Mogensen, Pardeep S Jhund, William T Abraham, et al.
JACC. Heart Failure|July 2, 2025
Incidence of Cardiac Arrhythmias Identified by Insertable Cardiac Monitors in Patients With Symptomatic Heart FailureRami Kahwash, Javed Butler, Muhammad Shahzeb Khan, et al.
Circulation. Heart Failure|September 14, 2016
Effects of Sacubitril/Valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background TherapyNaoki Okumura, Pardeep S Jhund, Jianjian Gong, et al.
Journal of Cardiac Failure|December 2, 2008
Application of implantable hemodynamic monitoring in the management of patients with diastolic heart failure: a subgroup analysis of the COMPASS-HF trialMichael R Zile, Robert C Bourge, Tom D Bennett, et al.
The American Journal of Cardiology|June 28, 2011
Left ventricular diastolic function and exercise capacity in community-dwelling adults ≥65 years of age without heart failureGilbert J Perry, Mustafa I Ahmed, Ravi V Desai, et al.
JAMA|October 20, 2020
Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: The CAPACITY HFpEF Randomized Clinical TrialJames E Udelson, Gregory D Lewis, Sanjiv J Shah, et al.
European Heart Journal|March 21, 2023
Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradoxJawad H Butt, Mark C Petrie, Pardeep S Jhund, et al.
Pageof 106

Showing results (831-840 of 1,060) with videos related to

Sort By:
Pageof 106
Journal of the American College of Cardiology|November 5, 2013
Impaired systolic function by strain imaging in heart failure with preserved ejection fractionElisabeth Kraigher-Krainer, Amil M Shah, Deepak K Gupta, et al.
American Heart Journal|February 23, 2021
Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trialsMuhammad Shahzeb Khan, Soren Lund Kristensen, Muthiah Vaduganathan, et al.
JACC. Heart Failure|May 13, 2019
Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HFCraig Balmforth, Joanne Simpson, Li Shen, et al.
Journal of the American College of Cardiology|November 18, 2017
Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection FractionUlrik M Mogensen, Pardeep S Jhund, William T Abraham, et al.
JACC. Heart Failure|July 2, 2025
Incidence of Cardiac Arrhythmias Identified by Insertable Cardiac Monitors in Patients With Symptomatic Heart FailureRami Kahwash, Javed Butler, Muhammad Shahzeb Khan, et al.
Circulation. Heart Failure|September 14, 2016
Effects of Sacubitril/Valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background TherapyNaoki Okumura, Pardeep S Jhund, Jianjian Gong, et al.
Journal of Cardiac Failure|December 2, 2008
Application of implantable hemodynamic monitoring in the management of patients with diastolic heart failure: a subgroup analysis of the COMPASS-HF trialMichael R Zile, Robert C Bourge, Tom D Bennett, et al.
The American Journal of Cardiology|June 28, 2011
Left ventricular diastolic function and exercise capacity in community-dwelling adults ≥65 years of age without heart failureGilbert J Perry, Mustafa I Ahmed, Ravi V Desai, et al.
JAMA|October 20, 2020
Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: The CAPACITY HFpEF Randomized Clinical TrialJames E Udelson, Gregory D Lewis, Sanjiv J Shah, et al.
European Heart Journal|March 21, 2023
Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradoxJawad H Butt, Mark C Petrie, Pardeep S Jhund, et al.
Pageof 106